Beyond Air, Inc. (XAIR)
About Beyond Air, Inc.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $3.7M
- Net income
- -$46.6M
- Total assets
- $30.1M
- Market cap
- $3.7M
- Gross margin
- 3.3%
- Operating margin
- -378.2%
- Net margin
- -447.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $7.7M
- Cost of revenue
- $7.4M
- Gross profit
- $252.0K
- Operating expenses
- $29.3M
- Operating income
- -$29.0M
- Net income
- -$34.3M
- EPS (basic)
- $-4.01
- EPS (diluted)
- $-4.01
Balance sheet
- Total assets
- $35.4M
- Current assets
- $24.8M
- Total liabilities
- $29.2M
- Current liabilities
- $6.5M
- Shareholders’ equity
- $6.2M
Cash flow
- Operating cash flow
- -$18.1M
- Investing cash flow
- -$3.7M
- Financing cash flow
- $29.1M
- Net cash flow
- $7.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $3.7M
- EPS (diluted)
- $-4.01
- Shares outstanding
- 652.3K
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 27, 2016
Beyond Air, Inc. (XAIR) Stock Price
- Reported a net loss of $46.6M in FY2025.
- Gross margin of 3.3%, net margin -447.1%.
- Trading 91% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Beyond Air, Inc..
Write a review
News about Beyond Air, Inc.
News & sentiment via Polygon.io
Beyond Air, Inc.: frequently asked questions
Is Beyond Air, Inc. an American company?
Beyond Air, Inc. is a US-based company headquartered in Garden City, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Beyond Air, Inc. headquartered?
Beyond Air, Inc. is headquartered in Garden City, New York, United States.
Is Beyond Air, Inc. publicly traded?
Yes — Beyond Air, Inc. is a publicly traded company. Its stock trades under the ticker symbol XAIR on the NASDAQ.
What does Beyond Air, Inc. do?
Beyond Air, Inc. is an American Medical Devices company in the Health & Beauty sector.
